John D. Gagnon

John D. Gagnon

Auto-generated profile, based on publicly available information

John D. Gagnon

Department of Microbiology & Immunology, University of California San Francisco

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2017 in Nature
Verified
Journal Article
Closed access
PDF file
DSDimitre R. Simeonov
Dimitre R. Simeonov
BGBenjamin G. Gowen
Benjamin G. Gowen
MBMandy Boontanrart
Mandy Boontanrart
TRTheodore L. Roth
Theodore L. Roth
JGJohn D. Gagnon
John D. Gagnon
AMAlex Marson
Alex Marson

21 August 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HBHozefa S. Bandukwala
Hozefa S. Bandukwala
JGJohn Gagnon
John Gagnon
STSusan Togher
Susan Togher
JGJason A. Greenbaum
Jason A. Greenbaum
ELEdward D. Lamperti
Edward D. Lamperti
ARAnjana Rao
Anjana Rao
Bromodomain-containing proteins bind acetylated lysine residues on histone tails and are involved in the recruitment of additional factors that mediate histone modifications and enable transcription. A compound, I-BET-762, that inhibits binding of an acetylated histone peptide to proteins of the bromodomain and extra-terminal domain (BET) family, was previously shown to suppress the production of proinflammatory proteins by macrophages and block acute inflammation in mice. Here, we investigated the effect of short-term treatment with I-BET-762 on T-cell function. Treatment of naïve CD4 + T cells with I-BET-762 during the first 2 d of differentiation had long-lasting effects on subsequent gene expression and cytokine production. Gene expression analysis revealed up-regulated expression of several antiinflammatory gene products, including IL-10, Lag3, and Egr2, and down-regulated expression of several proinflammatory cytokines including GM-CSF and IL-17. The short 2-d treatment with I-BET-762 inhibited the ability of antigen-specific T cells, differentiated under Th1 but not Th17 conditions in vitro, to induce pathogenesis in an adoptive transfer model of experimental autoimmune encephalomyelitis. The suppressive effects of I-BET-762 on T-cell mediated inflammation in vivo were accompanied by decreased recruitment of macrophages, consistent with decreased GM-CSF production by CNS-infiltrating T cells. These effects were mimicked by an inhibitor of c-myc function, implicating reduced expression of c-myc and GM-CSF as one avenue by which I-BET-762 suppresses the inflammatory functions of T cells. Our study demonstrates that inhibiting the functions of BET-family proteins during early T-cell differentiation causes long-lasting suppression of the proinflammatory functions of Th1 cells.

11 August 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
TSThomas B. Sundberg
Thomas B. Sundberg
HCHwan Geun Choi
Hwan Geun Choi
JSJoo-Hye Song
Joo-Hye Song
CRCaitlin N. Russell
Caitlin N. Russell
MHMahmud M. Hussain
Mahmud M. Hussain
ASAlykhan F. Shamji
Alykhan F. Shamji
Significance: IL-10 plays an essential role in maintaining gut immune homeostasis as evidenced by the link between genetic perturbation of this anti-inflammatory cytokine and inflammatory bowel disease (IBD). Here, we describe a small-molecule screen that identified inhibition of salt-inducible kinases (SIKs) as a strategy to enhance IL-10 production by macrophages and dendritic cells. Significantly, the IL-10–potentiating effects of SIK inhibition are associated with reduced secretion of the inflammatory cytokines IL-1β, IL-6, IL-12, and TNF-α, and these coordinated effects are observed in cells relevant to IBD including anti-inflammatory CD11c+CX3CR1hicells from murine gut tissue and in human dendritic cells and macrophages. Collectively, these results identify SIK inhibition as a promising approach to treat IBD by increasing gut IL-10 levels.

1 August 2019 in Cell Reports
Verified
Journal Article
Open access
JGJohn D. Gagnon
John D. Gagnon
RKRobin Kageyama
Robin Kageyama
HSHesham M. Shehata
Hesham M. Shehata
MFMarlys S. Fassett
Marlys S. Fassett
DMDarryl J. Mar
Darryl J. Mar
KAK. Mark Ansel
K. Mark Ansel
Coordinate control of T cell proliferation, survival, and differentiation are essential for host protection from pathogens and cancer. Long-lived memory cells, whose precursors are formed during the initial immunological insult, provide protection from future encounters, and their generation is the goal of many vaccination strategies. microRNAs (miRNAs) are key nodes in regulatory networks that shape effective T cell responses through the fine-tuning of thousands of genes. Here, using compound conditional mutant mice to eliminate miR-15/16 family miRNAs in T cells, we show that miR-15/16 restrict T cell cycle, survival, and memory T cell differentiation. High throughput sequencing of RNA isolated by cross-linking immunoprecipitation of AGO2 combined with gene expression analysis in miR-15/16-deficient T cells indicates that these effects are mediated through the direct inhibition of an extensive network of target genes within pathways critical to cell cycle, survival, and memory.

31 May 2019 in Genome Research
Verified
Journal Article
Open access
PDF file
ALAdam J. Litterman
Adam J. Litterman
RKRobin Kageyama
Robin Kageyama
OTOlivier Le Tonqueze
Olivier Le Tonqueze
WZWenxue Zhao
Wenxue Zhao
JGJohn D. Gagnon
John D. Gagnon
KAK. Mark Ansel
K. Mark Ansel
Compared to coding sequences, untranslated regions of the transcriptome are not well conserved, and functional annotation of these sequences is challenging. Global relationships between nucleotide composition of 3′ UTR sequences and their sequence conservation have been appreciated since mammalian genomes were first sequenced, but the functional relevance of these patterns remain unknown. We systematically measured the effect on gene expression of the sequences of more than 25,000 RNA-binding protein (RBP) binding sites in primary mouse T cells using a massively parallel reporter assay. GC-rich sequences were destabilizing of reporter mRNAs and come from more rapidly evolving regions of the genome. These sequences were more likely to be folded in vivo and contain a number of structural motifs that reduced accumulation of a heterologous reporter protein. Comparison of full-length 3′ UTR sequences across vertebrate phylogeny revealed that strictly conserved 3′ UTRs were GC-poor and enriched in genes associated with organismal development. In contrast, rapidly evolving 3′ UTRs tended to be GC-rich and derived from genes involved in metabolism and immune responses. Cell-essential genes had lower GC content in their 3′ UTRs, suggesting a connection between unstructured mRNA noncoding sequences and optimal protein production. By reducing gene expression, GC-rich RBP-occupied sequences act as a rapidly evolving substrate for gene regulatory interactions.

22 May 2015 in eLife
Verified
Journal Article
Open access
BKBernard Khor
Bernard Khor
JGJohn D Gagnon
John D Gagnon
GGGautam Goel
Gautam Goel
MRMarly I Roche
Marly I Roche
KCKara L Conway
Kara L Conway
RXRamnik J Xavier
Ramnik J Xavier
The balance between Th17 and T regulatory (Treg) cells critically modulates immune homeostasis, with an inadequate Treg response contributing to inflammatory disease. Using an unbiased chemical biology approach, we identified a novel role for the dual specificity tyrosine-phosphorylation-regulated kinase DYRK1A in regulating this balance. Inhibition of DYRK1A enhances Treg differentiation and impairs Th17 differentiation without affecting known pathways of Treg/Th17 differentiation. Thus, DYRK1A represents a novel mechanistic node at the branch point between commitment to either Treg or Th17 lineages. Importantly, both Treg cells generated using the DYRK1A inhibitor harmine and direct administration of harmine itself potently attenuate inflammation in multiple experimental models of systemic autoimmunity and mucosal inflammation. Our results identify DYRK1A as a physiologically relevant regulator of Treg cell differentiation and suggest a broader role for other DYRK family members in immune homeostasis. These results are discussed in the context of human diseases associated with dysregulated DYRK activity.